Other,increases
Other,ourProposedMethod
Other,Targeting
Other,highestSe
Other,tangshanPeople
Other,Using
Other,theirSelection
Other,dcisDiagnosis
Other,currentUtilizedHistopathologicBiomarkers
Other,HADS
Lifestyle,itsWater-bathSetup
Other,chlorambucilPlatinum
Other,importantNumber
Other,anti-her2Therapies
Other,trials
Other,higherDetectionRates
Other,longitudinalAssociation
Neuropathy,irregularHyperintenseLesion
Polymorphisms,polymorphismsImportant
Other,supplementalScreening
Other,breast
Other,unusualImmuneProfiles
Interval,note
Incorporation,workAbility
Incorporation,perceivedWorkAbility
Other,ck5/6
Distance,first
Provision,follow-up
Other,carboxyl-modifiedPegylatedPoly
Other,fluorescenceImagingExVivo
Other,proteins
Other,third-degree
Other,fiveYearRfsrate
Other,figures
Other,prophylacticBilateralSalpingo-oophorectomy
Other,upregulation
Other,shapes
Other,inImaging
Other,differentTreatmentModalities
Other,tertiarySexualHealthCenters
Other,entities
Other,learning
Other,cutoffValues
Plasticity,highSensitivity
Other,methylationStatus
Other,article
Neuropathy,commonPrimaryLesion
Other,significantHigherRisk
Other,random-samplingMethod
Other,usStandardization
Skin,itsExpressionLevel
Other,results
Other,analyses
Drugs,chemotherapyDrugs
Other,Pyrrolizinones
Other,methodsDesign
Interference,assessment
Other,furtherUnderstanding
Capillaries,capillaries
Other,-1
Other,counseling
Other,evidence
Other,totalOf121Patients
Other,erEvaluation
Other,challenge
Other,expressedCircularRnas
Other,growth
Other,finding
Other,inverseLongitudinalAssociation
Other,womenCarriers
Other,apoptosis
Other,rates
Other,variation
Other,those
Other,dysregulation
Other,targetingFxyd3-mediatedPathway
Other,costData
Other,metastasis-free
Other,Resurgery
Other,numericalFull-waveSimulation
Other,data
Other,miRNA
Aptamer,ssdnaAptamerMf3
Other,percecnt
Other,approach
Other,Applications
Other,five-yearLocalRecurrenceRates
Other,mitochondrialFission
Other,virtualReality
Other,trastuzumab
Other,outcome
Other,signalIntensity
Other,longScanTime
Other,edition
Probe,probe
Other,anticipatedOutcome
Other,symptomaticWomen
Provision,localControl
Other,recentDevelopments
Other,chemotherapyHormonalTreatment
Obstacle,hazardRates
Other,mastectomizedWomen
Other,SNPs
Other,molecularRegulatoryNetworks
Other,dictionaryLearning
Other,aim
Other,advancedAnalysis
Incorporation,ourStudy
Other,survivalRates
Other,anthracyclineChemotherapyAgents
Other,breastCancerCare
Other,cpgIslands
Other,186Pathology-provenS
Other,undifferentiatedNeoplasticCells
Other,kmt2aFusionGenes
Other,infiltrationSimilar
Other,increasedRisk
Lifestyle,signature
Other,variousNon-pharmacologicalAdjuvantTherapies
Other,Circ-EFCAB2
Other,NCCN
Other,Literature
Other,PFS
Other,networkOutput
Other,higher
Other,breastCancerStudies
Other,MRI
Other,newSignalPattern
Other,mastitis
Other,histopathologicDistinction
Drugs,usedDrugs
Other,commonCancerTypes
Other,foxc1Function
Other,retrospectiveReview
Other,detectionofBreastCancer
Other,oralBeta-sdgAdministration
Other,MetastaticLesions
Inhibition,Inhibition
Other,studies
Other,presence
Other,microfluidicPlatform
Other,medianTime
Incorporation,recentDanishCohortStudy
Other,signatures
Other,Change
Document,model
Other,Co-existence
Other,tissues
Derivatives,tripentoneDerivatives
Document,nsaidsExposure
Food,hotIssue
Cytology,mitochondrialMorphology
Extract,freshLeafEthanolicExtract
Cytology,fine-needleAspirationCytology
Other,sensor
Other,claimsDatabase
Other,divergences
Other,functionalAssessments
Other,adherence
Other,rnaKnockdown
Other,repair
Other,Hsa_circ_000178
Other,oneSpecificSubtype
Other,brain
Other,lesions
Other,axillarySurgery
Skin,cut-offBalfLevel
DNA,dnaMethylation
Lifestyle,objectiveResponseRate
Other,lowCtnLevels
Other,barcodeMode
Other,PB-DLL
Other,online
Other,genes
Other,breastCancerTreatment
Other,mostCommonOnes
Other,paTreatment
Resistance,mitochondrialTransmembranePotential-drivenRegulatedCellDeaths
Other,program
Sequencing,appropriateSequencing
Oestrogen,oestrogenReceptorAlpha
Granuloma,Granuloma
Other,conditions
Other,mostTumors
Other,volume
Other,racialDisparity
Other,complexConsulting
Other,Data
Other,practitionersKnowledgeable
Provision,breastCancerControl
Other,sectionLeads
Other,increasedRonExpression
Other,cm
Other,risks
Interval,imageQuality
Other,contrast-enhancedSpectralMammography
Other,considerations
Literacy,lowHealthLiteracy
Other,genitalTract
Other,advancedStage
Other,promoterMethylationStatus
Other,restoration
Other,extensiveExploration
Plasticity,uterineMass
Distance,boneDensity
Other,novelty
Other,fiveMutationCarriers
Other,occurrence
Appearance,significantDifference
Other,surgery
Other,tumorFluid
Other,involvement
Other,interview
Other,improvedDetection
Other,five-yearMetastasis-free
Other,regressionAnalyses
Other,manyComputerVisionApplications
Craniotomy,surgicalImplantationReconstruction
Other,confidentDiagnoses
Other,featureSubsets
Other,ourMethod
Other,homologousRecombinationPathway
Other,tract'sMetastases
Other,antibodyHerceptin
Other,miR-511
Other,SUM159PT
Food,cellCultureSupernatants
Functionality,oncogenicFunctionality
Plasticity,massProduction
Other,factor-1Scores
Other,female
Other,furtherResearch
Other,familyMembers
Other,commonComplaint
Other,dissection
Other,feasibilityStudies
Other,detection
Food,rural-basedTertiaryCancerCareCenter
Other,26
Other,predictors
Other,linkage
Other,Aims
Other,humanPapillomavirusScreening
Interval,chineseExpertGroup
Other,therapies
Other,examination
Other,mrnaLevels
Other,cytogeneticAnalysis
Other,Cryopreservation
Other,featureSelectionMethod
Other,severePneumopathy
Obstacle,brcc3Interference
Other,QALY
Hyperglycemia,hyperglycemia
Other,expressionLevels
Other,previousTherapy
Other,Survival
Other,westernBlotting
Other,humanEpidermalGrowthFactorReceptor2ReceptorStatus
Other,informationNeedsVary
Membrane,membraneTypeMannoseReceptor
Other,c1711
Food,specificFoodRecommendations
Other,furtherAdvancements
Other,immunohistochemistry
Other,informationNeeds
Skin,skinMetastasis
Other,osRate
Other,axillaryDissection
Other,distinctiveGeneticModifications
Other,survival
Other,oneMutation
Other,age-basedScreeningPrograms
Other,andfemales
Other,greatestImportance
Other,potential
Other,backgroundTrastuzumab
Other,histopathologicalreports
Other,its
Interval,medianLatencyTime
Other,historyPhysicalExamFindings
Other,breastCancerCases
Other,Acupuncture
Other,proteinKinaseC/extracellularSignal-regulatedKinasePathway
Polymorphisms,vdrPolymorphisms
Other,capacities
Other,otherInotherTertiaryCentres
Other,glut1Expression
Other,CNVs
Other,molecularTesting
Other,improvedUnderstanding
Other,manyBreastCancerPatients
Distance,focalAsymmetricDensity
Other,pdgfs/pdgfrsAxis
Other,sutegories
Other,cutaneousMetastasis
Other,Comparisons
Other,aberrantExpression
Appearance,appearance
Other,RT
Other,mothers
Other,herPresentation
Other,selectiveBinding
Other,diagnosis
Other,associations
Other,twoPathways
Neuromas,breastNeuromas
Other,stagingSystems
Other,familyHistory
Other,sialicAcidExpression
Other,breastCancerMetastasis
Other,scope
Other,measures
Other,complexSemisolidMasses
Other,performed
Other,CK
Other,Studies
Other,probableAnticancerMechanisms
Other,0-5Years
Other,know-howWe
Other,Probes
Other,700
Other,per2Expression
Other,adjustedProportion
Other,newFpReductionTechnique
Other,chinesePublic
Other,ourBreastCancerPatients
Other,tumorSite-specificInformation
Other,optimalCutoffValues
Sleep,otherAgeGroups
Other,extremeLearningMachineClassification
Other,scarceReports
Markers,markers
Other,femalePatients
Other,Univariate
Other,miR-34s
Other,Recurrences
Other,Ki67
Other,diagnosticEvaluation
Other,rareCases
Other,yearRfsrate
Other,magneticResonanceImaging
Other,she
Provision,currentFollow-up
Endocrine,adjuvantEndocrineHormonalTherapy
Document,balfContent
Obstacle,obstruction
Markers,epigeneticMarkers
Other,drugBinding
Other,surfaceArea
Other,mildHyperthermia
Other,Information
Mutations,Mutations
Other,mechanism
Other,sexualityEvidence
Other,independentReviewers
Sarcomas,forty-twoHigh-gradeSarcomas
Other,epigeneticAberrations
Other,adults
Other,408
Other,DOACs
Other,p
Other,aberrances
Other,recurrenceRates
Resistance,action
Other,immediateReconstruction
Other,youngMen
Other,we
Baseline,baselineSt-2Level
Probe,remarkableEnzyme-activatedNirFluorescentProbeNir-sn-ggt
Other,80
Other,morcFamilyCw-typeZincFinger4Overexpression
Other,featureSubset
Other,pathologicalSpecimen
Other,coxModels
Other,mammograms
Other,symptoms
Other,P
Other,mir-10aExpression
Other,characterization
Other,undergoing
Other,leucocytes
Other,Number
Other,comparisons10-yearSurvival
Other,colonyFormation
Other,concerns
Other,10Mg/kg
Document,exposure
Other,screeningPrograms
Other,molecularAnalyses
Other,reports
Other,measurements
Other,directRelationship
Other,technique
Other,breastUltrasound
Other,state-of-the-artAlgorithms
Other,cylindricalGeometries
Interference,theory-basedIntervention
Other,Mammography
Other,466Percecnt
Interval,period
Other,receptorTyrosineKinasePdgfrb
Interval,latencyPeriod
Other,cellDeath
Other,cancerFibroblasts
Other,This
Other,Demographics
Other,their
Other,proteinExpression
Other,14644Patients
Other,evidence-basedRecommendations
Other,relativeHospitalizedBleedingRisk
Other,trastuzumab/pertuzumab/taxane
Regions,enhancerRegions
Other,tolerabilitytheApatinib
Other,largeVariability
Other,rnaOligonucleotides
Other,itsUsefulness
Other,innateImmuneSystems
Other,double-maintenanceTherapy
Other,tumorAccumulation
Other,SVM-BRC
Other,propagation-basedPhase-contrast
Interval,controlGroup
Resistance,tediousCountingCell
Other,hybridCultures
Other,brcc3ExpressionLevels
Other,profiles
Other,significance
Other,cancerSusceptibilityGenes
Other,forwardProblem
Other,Lesions
Other,muchFocus
Other,bleedingRisk
Other,treatmentProtocols
Other,all
Other,sister
Neuropathy,chemotherapy-inducedNeuropathy
Other,youngestCohort
Neuropathy,lesion
Other,twenty-twoPatients
Other,imaging
Other,capabilities
Other,top10InformationalNeedContents
Other,greatPromise
Other,time
Other,molecularChanges
Other,relationship
Document,ddtExposure
Procedures,interventionalProcedures
Other,properties
Other,theirInhibition
Other,sosValues
Other,miceConditions
Incidence,incidenceTrendPlots
Other,propensityScoreMatchingAnalysis
Other,Lack
Interval,medianInterval
Other,pfh-ptx@plgaSpio-her
Other,Areas
Other,Belgium
Other,careProvider
Other,bl1-subtype
Incorporation,incorporation
Other,the
Extract,commonCause
Other,support
Other,crcPatients
Other,mutationEvents
Other,available
Other,shorterRadiotherapyRegimens
Other,ERN
Other,currentBio-sensingTechniques
Other,compounds19a
Other,highestRisk
Other,treatments
Other,identification
Complications,lateComplications
Other,short-termStrategy
Other,options
Other,parameterUncertainty
Images,mammographicImages
Other,development
Other,bleedingRates
Other,lowerNewBloodVesselsFormation
Other,extendedAdjuvantTreatment
Other,advance
Other,low-molecular-weightHeparin
Other,population
Other,contrastEnhancement
Other,circulatingSolubleRankl
Sleep,medianDiagnosisAge
Probe,oxidativeStressProbe
Complications,acuteComplications
Other,tumourigenesis
Other,strategies
Other,continuousPattern
Food,foodRecommendations
Interval,imageSegmentation
Other,prognosticValue
Other,simulation
Appearance,accuracy
Other,shift
Other,107ObservationalStudies
Other,eralphaTranscription
Other,77
Food,symptomaticHeartFailure
Other,ivimParameters
Other,bLymphocyteChemoattractant
Other,healthcarePolicyMakers
Other,imbalance
Other,flankingCgi
Other,threeParadigmaticExamples
MSOT,msotImaging
Other,radiotherapy
Other,epigeneticChanges
Other,omission
Other,gaslessRobot-assistedNipple-sparingMastectomy
Other,unbiasedRnaSequenceAnalysis
Other,parameters
Troponins,cardiacTroponins
Other,doses
Other,l-3
Other,simpleLow-costAlternative
Other,long-termUse
Other,rituximab
Other,robustSynthesisMethods
Other,occultBreastTumors
Other,easternAsianMusculoskeletalOncologyGroup
Other,caDetection
Extract,averageRisk
Other,countries
Other,trajectoryMembership
Plasticity,sensitivity
Other,third
Other,description
Probe,probeNir-sn-ggt
Other,herDisease
Other,dynamicContrast
Other,kmt2aFusionGeneTranscripts
Interval,tumorNippleDistance
Other,twoIndependentReviewers
Other,carbohydrateRestriction
Other,Diagnosis
Other,Diseases
Other,risk-stratifiedScreeningStrategy
Other,delay
Other,essentialRole
Covariance,covariance
Other,pooledUptake
Other,pik3caMutations
Other,threeDifferentClusters
Drugs,conventionalChemotherapyDrugs
Other,synchrotronSources
Food,experience
Other,ovarianMetastases
Other,cancerTherapy
Other,guidePatients
Other,years
Other,tumorCells
Other,contribution
Other,everolimus-exemestaneCombination
Other,research
Other,guidedImagery
Other,concurrentNeuroprotectiveDrugTherapy
Other,terms
Guidelines,internationalGuidelines
Other,It
Other,smallProportion
Other,medicalStatus
Other,mixedMethodsDesign
Skin,solubleSt-2Level
Other,importantPotential
Other,radicalSurgicalApproaches
Other,immunocytochemicalStudies
Provision,provision
Other,materialDetection
Obstacle,coxHazardRegressionModels
Other,microRNA
Other,bilateralInvolvement
Other,l-3Knockdown
Quantification,multidimensionalScaling
Other,factors
Other,subset
Other,vdrExpression
Other,existence
Lifestyle,mitochondrialResponse
Other,networks
Other,Downregulation
Other,postmenopausalPatient
Other,systematicCharacterization
Other,prostateCancers
Markers,solubleMarkers
Other,breastCancerScreening
Lymphedema,secondaryLymphedema
Other,perfluorohexane
Other,evolutionaryConservedCircularRnas
Other,occurringCancers
Other,8155Patients
Other,novelTargetedTherapeuticOptions
Membrane,membraneTypeMr
Other,occurring
Other,resultsDiagnosed
Other,haveCenterstage
Other,severalHer2-targetedTherapies
Other,10Percecnt
Other,significantIncrease
Other,microfluidicChips
Other,solubleMediators
Sleep,ageGroups
Other,supportVectorMachine
Other,circRNAs
Lifestyle,responseRate
Other,twoChlorambucilPlatinum
Distance,firstDose
Other,effectiveness
Other,itsRole
Interference,complication
Other,18FemaleNudeMice
Other,elevatedMitochondrialFission
Mammographic,Mammographic
Other,regulationMechanisms
Other,Cells
Other,Report
Other,testing
Other,supplements
Other,comparisonCohort
Other,differentPrognosis
Relapse,greaterthanorequalto10PercecntDecline
Other,invasion
Other,large-scaleStudies
Other,tumorInformation
Other,Efforts
Other,77Patients
Other,correlation
Other,morc4Silencing
Other,efforts
Other,itsRelevantLimitations
Other,secondValuedApproach
Other,Myeloma
Interval,medianLatencyPeriod
Incorporation,transferLearning
Other,S10
Other,omegaFattyAcids
Other,potentialReduction
Other,cutoffValue
Other,patient'sHistory
Other,matchedHealthyTissues
Other,clinicalDepression
Other,contraceptiveUse
Other,inclusion
Complexes,dynamicSh2ProteinComplexes
Other,highHeterogeneity
Other,fisherAnalysis
Other,protocol
Extracts,pseuderanthemumPalatiferumRadlkExtracts
Other,association
Other,survivalRate
Other,shallowCnn
Incorporation,study'sObjectives
Other,breastReconstruction
Other,Residents
Other,back-splicingMechanism
Other,probableMechanisms
Other,risk
Probe,osteopontin-basedProbe
Other,differentProtocols
Other,hundreds
Other,ai-associatedTendinopathy
Other,quality
Other,Researchers
Other,twoTumorGroups
Skin,skinMetastases
Resistance,lungCellCarcinomas
Other,clinicalPicture
Other,OR
Other,recentEpigenomeStudies
Membrane,paraneoplasticAntibodyPanel
Other,caloricRestriction
Other,pharmacologicalInduction
Other,5Percecnt
Other,inhibited
Other,digitalBreastTomosynthesis
Other,ctnLevels
Other,personalDecision-making
Other,nuclearFactors
Other,lowClassificationAccuracies
Other,uptake
Other,parallelDetection
Other,ca15-3Detection
Other,distinction
Other,wavelengthConsistencyIndex
Dysplasia,regressionModels
Other,deep-CNN
Other,locoregionalRadiotherapy
Other,nano-genosensor
Other,knockdown
Other,They
Other,26894People
Other,comparison
Other,costs
Other,nippleInvolvement
Other,95PercecntConfidenceIntervals
Nondestructive,nondestructiveTesting
Other,20
Other,mrSystems
Interval,medianFollow-upPeriod
Other,mriProtocols
Other,primaryBreastCarcinoma
Other,first-lineTreatment
Other,healthCenters
Nondestructive,mostNondestructiveTests
Other,novelMethod
Other,contrastAgents
Other,positiveChanges
Other,substantialImprovements
Other,collectedSignatures
Other,Trends
Other,adverseEffects
PET/CT,f-fdgPet/ct
Other,suchStandardization
Other,cohort
Other,Treatment
Other,anti-her2Therapy
Other,mab1e3
Other,importantRole
Interval,latencyTime
Other,secondLargestHmo
Other,rapidAdvancements
Other,hugeVolumes
Other,pseudotumoralAspect
Lifestyle,three-lncrnaSignature
Stigmatization,mostStigmatization
Extracts,leafExtracts
Other,risk-reducingStrategies
Other,interpretation
Other,fibroblastsAdjacent
Other,screeningTools
Other,bivariateAssociations
Other,wordCloud
Other,noninvasiveImaging
Other,160Patients
Other,publicHealthCareSystem
Other,56Patients
Other,deepLearning
Exposure,excellentPerformance
Other,opticalAbsorptions
Other,detailedRoles
Other,mriTechniques
Dysplasia,regressionAnalysis
Other,platform
Other,paper
Other,bindingSites
Other,mostStudies
Other,largerStudies
Other,prevention
Other,use
Other,scan
Other,simulationStudies
Other,therapy
Other,Access
Other,Speed-of-sound
Other,multivariate
Other,compounds
Surgeries,complexSurgeries
Other,prospectiveStudies
Other,medicalKnowledge
Other,sevenWomen
Other,increasedPer2Expression
Other,preoperativeUnderstanding
Other,metastaticBreastCancer
Other,highCorrelation
Other,flowRate
Other,directEffects
Other,factorAnalysis
Other,biologicalHeterogeneity
Other,classifiers
Exosomes,exosomesDerivedCk19
Other,necessity
Other,diagnoses
Other,most
Other,screeningStrategy
Other,nationwideSurvey
Other,combinedAnalysis
Other,Findings
Similarities,similarities
Other,sixCirculatingMirnas
Other,need
Other,role
Other,22Deaths
Other,targetVolume
Other,54BreastCancerPatients
Other,switch
Other,sox9NucleusEntry
Other,lymphNodeRatio
Other,speed
Other,they
Other,estrogenReceptorBeta
Other,35-64Years
Other,initialResults
Document,higherBalfContent
Other,sampleSizes
Other,her2-targetedTherapies
Other,definition
Other,murineMonoclonalAntibodies
Other,knowledgeSummaries
Other,traditionalPredictors
Metformin,metformin
Obstacle,summaryHazardRatios
Other,Isolation
Other,late-phaseClinicalTrials
Other,screening
Resistance,netvizzApplication
Membrane,combinedPanel
Other,pD1542yMissenseMutation
Other,histoneModifications
Skin,balfLevel
Other,hypomethylationSites
Other,cancerRiskPerception
Other,insight
Obstacle,lowerCumulativeHazardRates
Other,40
Other,ourResults
Interference,drugDeliveryStrategies
Other,osAdvantage
Other,resonanceImaging
Other,428BreastCancerPatients
Document,threePapers
Other,post-radiationVascularLesions
Polymorphisms,polymorphisms
Other,12-15Percecnt
Other,kaplan-meierCurves
Other,differentLong-termSurvival
Other,proposedMethod
Other,lymphedemaseventyPatients
Other,Uncertainties
Other,mastectomy
Other,multiparametricMri
Document,ourLiteratureReview
Other,syndromes
Mortality,mortalityRates
Other,familySupport
Other,serumCrust
Other,t2bSutegory
Other,obstetricians
Other,outcomes
Other,adjuvantRadiotherapy
Hyperglycemia,effect
Other,algorithm
Other,mutationCarriers
Other,severalIndividuals
Isolation,ctcIsolationTechniques
Surgeons,Surgeons
Other,transitionProbabilities
Traumatic,traumaticBreastNeuromas
Other,Rituximab
DNA,abnormalDnaMethylation
Other,186S
Other,11HereditaryBreastCancerGenes
Mastectomies,bilateralMastectomies
Other,survivalDifferences
Other,multigenePanels-with
Resection,Resection
Other,one-thirdCases
Other,chemotherapy
Other,rnaSequenceAnalysis
Other,commonFinding
Other,theResulting
Other,NLR
Other,intelligentTechniques
Other,mostPretermBirth
Other,Disease
Other,recommendations
Other,substantialRacial/ethnicDisparity
Other,itsImportantRole
Other,encapsulatedSuperparamagneticIronOxideNanoparticles
Food,assay
Other,increase
Other,combination
Other,enforcedExpression
Other,89Participants
Other,bioactivity
Other,survey
Other,aberrations
Other,15Percecnt
Other,preventiveStrategies
Other,mmp2Genes
Plasticity,massMedia
Interval,absence
Other,textureFeatures
Baseline,baselineSolubleSt-2Level
Other,hospitalCohort
Other,specificityImprovement
Other,pulmonaryMetastases
Other,mechanisms
Other,recurrence-free-survival
Cytology,needleAspirationCytology
Other,bestAvailableEvidence
Other,mostPatients
Other,overexpression
Other,comprehensiveSearch
Other,stage
Appearance,oneCase
Other,proposedAlgorithm
Other,microRNAs
Other,manyFeatures
Other,underlyingIncrease
Other,thepresence
Other,Referrals
Other,frequentCancer
Lifestyle,lifestyleFactors
Other,towaveletFilter
Exosomes,ca125-richExosomes
Other,MicroRNAs
Sequencing,therapeuticSequencing
Other,these
Other,BRCAs
Other,receptorActivator
Sprays,ddtSprays
Distance,density
Other,overallMediumSecondTumor-freeTime
Other,aggressiveManagement
Appearance,accuracyScores
Other,Japan
Other,archivedFormalin-fixedParaffin-embeddedTissue
Other,receiving
Other,Rainbow
Other,additionalInformation
Other,elevenPatients
Other,Cases
Other,ernGenturis
Other,treatmentCompletion
Disruption,disruption
Other,vulnerability
Other,decreasedRisk
Other,ptyrProteins
Other,SPIO
Obstacle,block
Other,youngMalePatients
Other,coverageRates
Membrane,antibodyPanel
Obstacle,majorObstacle
Other,DCR
Other,syndrome
Other,little
Other,9398
Provision,controlTrial
Other,respondents
Other,simulatedBreastCancer
Other,twoScales
Other,ironOxideNanoparticles
Other,alveolar-interstitialLesions
Other,primaryTumours
Interval,image
Other,Symptoms
Other,Angiogenesis
Other,usefulness
Late-stage,late-stageCancerDiagnosis
Other,smallMoleculeInhibitors
Other,target
Interference,intervention
Other,five-yearOsRate
Other,49Patients
Other,remarkableImprovements
Other,decreases
Other,Risk
Other,pfBiomarkers
Other,osteopontin-750Accumulation
Other,numerousStudies
Other,conservativeTreatment
Other,cancerAssociatedFibroblasts
Other,emergingTechnology
Other,PF
Other,inGrowth
Craniotomy,craniotomy
Other,relapseRates
Other,0.84
Interval,interval
Other,clb-pt-clbProdrug
Scoring,Scoring
Other,localizedDescription
Other,cancerStaging
Resistance,theirApplication
Other,peripheralBloodSamples
Other,novelPowerfulTechnique
Dysplasia,multivariableLogisticRegressionAnalysis
Other,appropriateInterpretation
Other,-916
Other,We
Other,interaction
Exosomes,exosomesCk19
Other,stageIv
Other,Metastases
Cytology,fineNeedleAspirationCytology
Other,actualIncidence
Granuloma,EosinophilicGranuloma
Other,itsRelativeClinicalSignificance
Other,routineUse
Other,subjectiveRisk
Other,breastCancer-specific10-yearSurvival
Other,stereotacticWire-guidedBiopsy
Other,steps
Other,mammography
Exposure,equivalentPerformance
Other,PM
Other,surgicalOutcome
Other,genitalTract'sMetastases
Other,denosumabInjection
Other,correlationCoefficient
Other,differentStudies
Other,Irradiation
Other,strategy
DNA,aberrantDnaMethylation
Provision,cancerControlPlanning
Other,medianOs
Other,biomarker
Other,mir-511Overexpression
Other,complaint
Other,majorAdvance
Other,23Patients
Obstacle,blockade
Appearance,characteristicExosomalTumorMarkers
Other,pi3k/aktSignaling
Other,theirCardiotoxicities
Other,muchInterest
Other,65-year-oldFemale
Other,Zt/g4-MMAE
Other,helaCells
Document,nsaidExposure
Food,coreNeedleBiopsy
Exposure,discovery
Other,tomography
Other,challenges
Other,dose
Other,SUMMARY
Other,RON
Other,essentialsBleedingRisk
Other,antigenIdentification
Other,maintainedBreastCancerDatabase
Other,mortalityRate
Nondestructive,nondestructiveTests
Relapse,betterOs
Other,h&eStaining
Other,systematicReview
Other,transcriptionFactorForkheadBoxC1
Other,Overexpression
Other,mortality
Other,12404Patients
Other,roles
Other,ultrasound-guidedDiffuseOpticalTomography
Other,reporterAssays
Other,interplay
Other,treatmentOutcomePrediction
Other,tenfoldCross-validationMatthew
Other,circularRnas
Other,inhibitors
Food,cancerCareCenter
Other,additionalAnalyses
Other,Depletion
Other,eighthEdition
Other,ORR
Malformation,malformationInduction
Other,components
Exosomes,circulatingExosomes
Other,purpose
Other,solidTumor
Other,imagingFeatures
NSAID,nsaidUsers
Other,proteinKinaseCInhibitors
Other,roboticSurgicalSystems
Other,sentinelNodeBiopsy
Other,pattern
Other,programs
Other,segmentationAlgorithm
Other,spc24Knockdown
Other,manyPatients
Other,surgeon
Other,30Cm
Other,realDataAnalysis
Interval,group1
Pathogenic,pathogenicVariants
Provision,agreement
Other,Kazakhstan
Other,4248BreastCancerPatients
Other,circulatingBiomarkers
Other,Breast
Provision,2-groupRandomizedControlTrial
Other,ELISA
Other,immunohistochemicalAnalysis
Other,precision
Obstacle,coxProportionalHazardRegressionModels
Other,27-36MillionPatients
Other,10-foldCross-validation
Other,STAT1
Other,sustainedStableDisease
Neuropathy,adhesionProtein-1
Other,frequentLateRelapses
Other,improvement
Other,breastCancerPatients
Resistance,CellLines
Other,S7
Other,physician
Exposure,betterPredictionPerformance
Other,CNN
Other,patient'sMedicalHistory
Other,Utilization
Provision,moreIntensiveFollow-up
Other,expectedInverseCorrelation
Other,sexualityMoreEvidence
Other,Follow-up
Other,pyrrolizin-9-one
Other,furtherDevelopment
Skin,st-2Level
Food,multiplexAssay
Provision,control
Other,fewStudies
Other,survivalDistributions
Other,recurrence
Other,longNoncodingRnas
Other,brd4Regulation
Other,world
Interval,keyHypomethylationSites
Other,TAAs
Other,induction
Other,status
Other,pathologicalResults
Other,decision
Other,relatedTranscriptionFactorSox9
Other,jak-statPathway
Other,chemotherapyGroups
Resistance,resistance
Other,unenhancedMriTechniques
Quantification,successfulQuantification
Other,paradigmaticExamples
Other,methods
Other,priorMedicalHistory
Other,subsequentAxillaryLymphNodeDissection
Extract,leafExtract
Articles,Articles
Other,nsclcSamples
Obstacle,coxHazardRegressionAnalysis
Other,subsequentRadiomics
Craniotomy,excision
Other,adult1-yearCancerSurvivors
Other,suchSymptoms
Other,transcoelomic
Other,none
Other,higherResolution
Other,100000Person-years
Other,centralImplantedVenousAccessDevices
Other,measurementSystem
Other,value
Other,ruralCancerHospital
Other,reverseTranscription-quantitativePolymeraseChainReaction
Other,otherData
Other,oncologyGroup
Other,beta-SDG
Other,effects
Other,three-yearSurvivalRates
Aptamer,aptamerMf3
Other,sentinelLymphNodeBiopsy
Other,positiveTreatment
Other,comprehensiveResearchData
Other,australianSynchrotron
Other,resultsAberrantExpression
Incorporation,cross-sectionalStudy
Other,cells
Other,ourFindings
Other,commonOnes
Other,CLB-Pt-CLB
Isolation,feasibleCtcIsolationTechniques
Provision,littleHelp
Other,largeBreastCancerTissueMicroarray
Other,CEDM
Mastectomies,mastectomies
Other,members
Other,ongoingTrials
Other,fpReduction
Other,principles
Other,LMICs
Other,total
Sarcomas,high-gradeSarcomas
Incidence,incidenceRates
Contraception,contraceptionUse
Other,481Women
Other,Development
Other,Validation
Procedures,procedures
Other,Investigation
Skin,dichlorofluoresceinLevel
Other,interleukin6
Cytology,morphology
Other,ipsilateralBreastRecurrence
Other,breastImagingModality
Other,polymeraseChainReaction
Other,focus
Other,lisbonRegion
Other,fewLmics
Other,neoadjuvantChemotherapyGroups
Other,higherProportion
Other,rate
Other,five
Other,allBreastCancerPatients
Other,similarTowaveletFilter
Other,secondaryLymphomatousInvolvement
Other,parpInhibitors
Other,hugeImprovement
Other,alternativeContrast-enhancedScreeningTools
Other,mPatients
Other,microrna-22ExpressionLevels
Other,water
Food,mtorInhibitorEverolimus
Sleep,medianAge
Other,secondTumor
Other,fastingBlood
Other,dual-luciferaseReporterAssays
Other,tnmStaging
Other,medianProgression-freeSurvival
Other,recognizingMethylationStatus
Other,understanding
Other,problem
Other,sosReconstruction
Other,patient'sTumorBurden
Interval,keyRole
Other,resultsExpression
Other,otherFactors
Provision,criticalScientificBase
Other,heterogeneity
Other,22Patients
Other,consolidativeRadiotherapy
Other,filipinoWomen
Other,ourAim
Troponins,troponins
Other,higherRisk
Other,luminalB-likePatients
Other,prophylacticCranialIrradiation
Other,inhibition
Other,incidence
Other,histologicExamination
Other,lipidProfiles
Other,greatestDivergences
Other,poly
Other,researchDevelopment
Other,optimalCut-offValue
Other,breastScreening
Other,APBI
Other,cancerSurvivors
Other,underlying
Other,biocompatiblePfh-ptx@plga
Other,lessBleeding
Other,83Percecnt
Resistance,leafMda-mb-231CellDeath
Other,search
Other,oneCancer
Other,review
Other,breastConservation
Other,breastCancerRisk
Other,advances
Other,mass/es
Other,breastCancerDetectionMethod
Dysplasia,zero-inflatedPoissonRegression
Other,Differentiation
Other,GTPase
Other,radiomics
Exosomes,tumorInterstitialFluidDerivedExosomes
Other,score
Other,malePatients
Other,directTargetGene
Exosomes,exosomes
Other,highIndex
Other,prognosticStagingSystems
Other,dualRole
Other,biomarkers
Other,sparseCoding
Other,Review
Other,blackWomen
Other,hypothesis
Other,controls
Other,tailoredConsiderations
Other,experts
Other,ourData
Other,binding
Other,Epidemiology
Document,papers
Other,monteCarloFeatureSelection-basedFeatureSelection-basedComputationalMethod
Other,yoga
Other,neoadjuvantChemotherapy
Other,correctDiagnosis
Other,overview
Other,Promoting
Other,trends
Other,positiveFeedbackLoop
Other,meta-analyses
Cytology,breastCancerGenetics
Other,included
Other,strongContrast
Other,specificSubtype
Complexes,phosphotyrosineProteinComplexes
Other,adPatients
Other,Transcripts
Other,lack
Endocrine,menopausalHormoneTherapy
Other,histopathologicalAnalysis
Other,mriImaging
Other,betterUnderstanding
Other,resistantCells
Other,coding
Other,analysis
Other,ourPatient
Other,CTCs
Other,suggesting
Other,severalIntelligentTechniques
Other,information
Computer,Computer
Other,27b
Other,20BreastCancerPatients
Incorporation,studyObjective
Other,Management
Resistance,vitaminDActivity
Cytology,invasiveLobularHistology
Other,characteristics
Other,commonAdultCancers
Other,DDTs
Document,estrogenicExposure
Other,continuousRisk
Other,knowledge
Other,Radiotherapy
Other,disease
Other,mutationRatio
Other,biologicalSubtypes
Almaty,almatyCity
Cavernous,cavernousMalformationInduction
Resistance,physicalActivity
Other,identified
Complications,occasionalComplications
Other,tumorGroups
Other,DOACS
Other,cornerstone
Other,similarExperimentalParameters
Other,ruralSetting
Other,vap-1Expression
Issues,issues
Other,plasmaLevels
Other,20-year-oldWoman
Other,particleSwarmOptimizationAlgorithm
Covariance,proposedCovariance
Other,protocols
Dysplasia,regressionModel
Other,tissueBiopsy
Analytics,dataAnalytics
Other,cutoff
Applicability,clinicalApplicability
Other,vap-1NegativeStaining
Other,commonCancer
Other,mainMeasures
Other,mpMRI
Other,alternativeOption
Document,literature
Other,c.
Other,microscopicTesting
Other,strongAssociation
Other,oncoproteins/cancerSuppressors
Other,SP
Other,newCancerCases
Document,coxModel
Other,of121Patients
Other,techniques
Collision,impact
Other,hereditaryBreast
Other,selectedOptimalFeatureSubsets
Other,ductalCarcinoma
Other,Factors
Transmembrane,mitochondrialTransmembranePotential
Other,44Percecnt
Provision,screeningBehavior
Other,99Percecnt
Other,individuals
Other,aspirinTherapy
Other,Biomarkers
Other,itsExpression
Food,education
Other,cancerResearch
Other,CESM
Other,MethyLight
Other,staining
Other,medianOverallSurvival
Autoantibodies,autoantibodies
Other,smallPopulation
Sequencing,sequencing
Probe,specificEralpha-targetedProbe
Other,Images
Other,theirEmergingRole
Markers,tumorMarkers
Provision,exercise
Other,result
Resistance,capacitance
Skin,geneExpressionLevel
Other,rateIncrease
Other,alexnetModels
Other,improvedCancerTreatment
Other,acceleratedPartialBreastIrradiation
Incorporation,followingStudy
Analogs,their5h-pyridoPyrrolizin-5-oneAnalogs
Analogs,theirPyrrolizin-5-oneAnalogs
Other,mStage
Other,
Other,function
Other,femaleNudeMice
Other,t2Category
Other,25-year-oldWoman
Other,prognosis
Other,cTn
Other,PFH-PTX@PLGA
Other,diagnosticPfBiomarkers
Other,sites
Other,roboticSystem
Other,aspects
Other,geometries
Other,diseases
Other,2921Posts
Other,geneticChanges
Other,itsDeregulation
Other,idiopathicGranulomatousMastitis
Document,document
Derivatives,activeDerivatives
Other,clinicopathologicalSignificance
Other,ratio
Other,volumes
Other,clinicalBreastExamination
Other,antibody-anchoredMagneticBeads
Other,picture
Other,bioimpedanceAnalysis
Other,menopause
Other,pharmacokineticParameters
Other,prediction
Other,mirnaExpressionProfiles
Other,usExaminations
Other,conjugatedEquineEstrogen
Other,standardizedImagingProtocol
Other,hormone-dependentPositiveBreastCancer
Other,markedReduction
Plasticity,plasticity
Plasticity,tumorWeight
Other,obtainedFeatures
Other,deregulatedMirnas
Other,manyWomen
Other,complexTreatmentAlgorithms
Other,oneHundredElevenPatients
Other,clinicalCharacteristics
Other,method
Resistance,application
Other,incidenceRates
Hyperglycemia,cell-killingEffect
Other,Genetic
Other,beta-Sitosterol-d-glucoside
Other,biopsy
Other,diagnosisSystem
Other,advancedBreastCancerBearingMutations
Provision,activation
Late-stage,late-stage
Other,hospitalizations
Other,differentiation
Other,primaryCareProvider
Other,salpingo-oophorectomy
Individuals,Individuals
Other,chemotherapyRegimens
Other,responsibleMechanisms
Other,age-matchedSystematicRandom-samplingMethod
Other,952PercecntOfthePostmenopausalWomen
Other,pathways
Other,fission
Other,volumetricMeasurementSystem
Other,tumorSuppressorFunction
Other,typicalWoman
Other,miRNAs
Other,greatProgress
Other,charts
Other,84Patients
Collision,recurrentWords
Other,Patients
Other,2Patients
Other,migration
Other,mainTwoEntities
Other,variousMethods
Other,intensive
Cytology,cytology
Other,clinicians
Other,hospitalizedBleedingRisk
Other,goodTolerabilitytheApatinib
Other,furtherImaging
Disruption,intrinsicDisruption
Other,clinicalRecords
Other,highGlut1Expression
Other,handicap
Other,CGI
Other,higher-qualityImaging
Other,Use
Other,majority
Other,theirLong-termSurvival
Other,leaves
Relapse,relapse
Other,133BreastCancerCases
Other,theirSurvival
Other,sexes
Other,epidemiologicalFeatures
Other,hsa-miRNA-143-3p
Other,specimen
Other,youngPatients
Other,subtypes
Document,limitedLiterature
Other,Non-linearity
Other,convolutionalNeuralNetworks
Other,selectedPatients
Other,definedSubtype
Other,multipleGeneticAberrances
Dysplasia,binaryLogisticRegressionModels
Other,rareTumor
Skin,aromataseInhibitor-inducedBoneLoss
Other,9h-pyridoPyrrolizin-9-one
Other,simulatedInnerBreastTissue
Other,label-freeDetection
Other,features
Other,Analysis
Other,mostBreastDiseases
Skin,level
Other,proteinKinaseCInhibition
Areola,nippleAreolaComplexInvolvement
Other,strongLinkage
Other,olderWomen
Other,cent
Other,aberrantMethylationDetection
Other,furtherStudies
Other,node
Other,neutrophil-to-lymphocyteRatio
Other,healthcareUtilization
Other,riskFactors
Other,amino-terminalFragment
Other,Importantly
Other,positronEmissionTomography
Other,experiences
Other,fxyd3Amplification
Sleep,age
Other,severalPatients
Probe,stressProbe
Lifestyle,response
Interference,newerDrugDeliveryStrategies
Other,mammographicBreastCancerScreening
Other,mainObjective
Other,randomisedTrials
Other,overallMedianSurvival
Other,diagnosed
Resistance,anticoagulantChoice
Other,neoadjuvantTreatment
Other,potentNon-secosteroidalVdrModulator
Appearance,caseReport
Other,systematicSearch
Other,similarSeriousAdverseEvents
Lifestyle,subtype-specificSignature
Nanoplatform,theranosticNanoplatform
Other,accurateMethod
Other,breastBiopsies
Users,12331Users
Other,decreasedExpression
Other,Steps
Dysplasia,finalMultipleRegressionModel
Other,evaluation
Other,systems
Complexes,dynamicSh2Domain-scaffoldingProteinComplexes
Other,objective
Other,otherDietaryRecommendations
Other,brcanessPhenotype
Other,clinico-pathologicalRiskFactors
Other,observationalStudies
Plasticity,mass
Other,estrogenReceptor
Other,considerableNumber
Other,Cell
Other,main
Complexes,phosphotyrosineRegulatedProteinComplexes
Resistance,multidrugResistance
Other,Therapies
Other,compactSynchrotronSources
Other,highVariability
Other,100Patients
Food,goal
Cytology,histology
Other,hypomethylation
Resistance,transmembraneCellDeaths
Other,pathway
Other,1444Women
Other,outliers
Other,brd4Inhibition
Other,recentStudies
Other,pax6promoterMethylation
Incorporation,study
Other,oncologicRisk
Other,brd4PharmacologicalInhibition
Other,alternative
Endocrine,endocrineResistance
Other,2060Women
Other,standard
Other,it
Other,clinicalFeatures
Other,metabricTrainingSet
Other,longerPfs
Other,proportion
Incorporation,prospectiveNestedCase-controlStudy
Other,percecntConfidenceIntervals
Other,19
Other,fpReductionTechnique
Other,subtype
Other,availableContrastAgents
Resistance,freshLeafEthanolicExtract-treatedMda-mb-231CellDeath
Granuloma,neuroma
Other,606Percecnt
Other,targetedTherapies
Other,splenicLymphocytes
Other,DAU
Scoring,nuclearAtypiaScoring
Other,causes
Other,ctcCounts
Other,tools
Appearance,case
Other,familialCancerClustering
Other,cross-validation
Other,brcc3Expression
Other,targetedTumorAccumulation
Other,lobularCarcinoma
Other,survivalData
Other,differentialExpression
Other,breastSurvival
Other,stromalExpression
Other,mainChallenge
Other,dose-dependentReduction
Other,summary
Other,methylation
Distance,firstTime
Other,importantCornerstone
Other,limited-angleFourier-domainSosReconstruction
Other,modificationPathways
Other,trend
Other,aspect
Other,significantAdvances
Membrane,panel
Other,expression
Other,antibodies
Other,output
Complications,complications
Other,limitedHealthSystemCapacities
Other,essentialsRisk
Other,535941Survivors
Other,bloodVesselsFormation
Other,12SampledWomen
Other,localTherapy
Other,history
Extract,cause
Other,Anthracyclines
Other,China
Other,findings
Other,localRecurrence
Other,treatment
Other,RNAs
Other,differentialDiagnosis
Other,metabolicTargetVolume
Other,brainMetastases
Other,interactionEffects
Other,monteCarloFeatureFeatureMethod
Other,stableDrug-carrierBinding
Other,1000Patients
Users,12331Non-nsaidUsers
Other,proposedTechniqueResults
Other,metabolicChanges
Other,xenograftMice
Obstacle,catheter-relatedObstruction
Interference,postOperativeAssessment
Other,otherSignificantConcerns
Other,+239Percecnt
Other,conventionalMagneticResonanceImaging
Stigmatization,stigmatization
Cytology,aspirationCytology
Interference,postAssessment
Incorporation,two-yearStudy
Other,found
Other,underlyingCauses
Relapse,breastCancerRelapse
Guidelines,guidelines
Other,breastExamination
Other,maintenance
Other,inverseProblem
Other,statisticalClassifiers
Dioxide,carbonDioxideLaserTechnology
Other,textureAnalysis
Other,geneExpressionData
Other,subgroupVariables
Other,growthPotential
Other,immediateUnmetNeed
Other,bloodSamples
Other,transport
Distance,eConcentration
Other,increasingNumber
Other,separateClassificationModels
Other,suutaneousBreastTumor
Other,Screening
Nanoplatform,nanoplatform
Other,postmenopausalWomen
Other,radiomicsScore
Relapse,betterUnderstanding
Other,133Controls
Other,sensitiveNano-genosensor
Other,anti-ronMonoclonalAntibodyZt/g4-drugMonomethylAuristatinEConjugate
Neuropathy,18-fdgFlux
Other,uterineTumors
Other,currentAnalysis
Other,sonography
Other,abbreviatedMriProtocols
Other,earlyBreastCancerDetectionSystems
Endocrine,gonadotropin
Other,obstetrician
Distance,itsFirstDescription
Other,detailedAnalysis
Other,variants
Provision,disturbance
Other,involved
Other,drugTherapy
Other,SD-CNN
Cytology,surfaceMorphology
Other,conventionalX-rayMammography
Other,recurrentHyperprolactinemia
Other,tanUsage
Other,oxidationPeakCurrent
Other,cases
Other,clinicalOutcomesDiffer
Appearance,caseRecords
Other,gsAlgorithm
Other,concentrations
Resistance,cell
Other,reality
Other,Biopsy
Other,She
Exposure,performance
Other,palliativeChemotherapy
Other,METHODS
Other,synthesisMethods
Other,rs5743810ProAllele
Other,mainContribution
Endocrine,humanChorionicGonadotropin
Other,numerousGene-expression-basedPrognosticSignatures
Incorporation,cohortStudy
Other,multiresolutionResult
Other,each
Appearance,difference
Other,promoterdnaMethylation
Probe,nirProbeNir-sn-ggt
Other,pax6Inhibition
Other,numberVariants
Other,meanTime
Obstacle,multivariateCoxProportionalHazardRegressionAnalysis
Other,pax6Overexpression
Contraception,hormonalContraceptionUse
Other,mutations
Other,fisherDiscriminantAnalysis
Other,Prevalence
Other,immunohistochemicalProliferationMarkerKi67
Other,conclusionsWomen
Other,sensitiveCells
Other,importance
Other,changes
NSAIDs,NSAIDs
Other,asymptomaticWomen
Other,subacuteEffects
Other,Sutegorization
Appearance,change
Craniotomy,surgicalExcision
Other,vap-1StainingResults
Other,lymphocytes
Granuloma,traumaticNeuroma
Other,number
Other,Identification
Cytology,intraoperativeScrapeCytology
Other,blood
Other,fibroblasts
Other,MultipleMyeloma
Other,promisingSupplements
Other,hsa_circRNA_102101
Other,imagingTechnique
Other,similarPfs
Resistance,activity
Other,psychologicalAspects
Appearance,theirAbility
Other,ourTheoreticalAnalysis